Clinical Trial

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 at fasting state.
Protocol Amendment History 2 changes
critical Trial completed 2026-04-01
notable Primary completion pushed: 2026-01 -> 2026-01-31 2026-04-01
Trial Details
NCT Number NCT07297940
Lead Sponsor Dong-A ST Co., Ltd.
Conditions Healthy
Enrollment 42 participants
Start Date 2025-12-14
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-31